Amsterdam Public Health

Adverse drug events caused by three high-risk drug–drug interactions in patients admitted to intensive care units: A multicentre retrospective observational study

Klopotowska, J. E., Leopold, J-H., Bakker, T., Yasrebi-de Kom, I., Engelaer, F. M., de Jonge, E., Haspels-Hogervorst, E. K., van den Bergh, W. M., Renes, M. H., Jong, B. T., Kieft, H., Wieringa, A., Hendriks, S., Lau, C., van Bree, S. H. W., Lammers, H. J. W., Wierenga, P. C., Bosman, R. J., de Jong, V. M., Slijkhuis, M., & 11 othersFranssen, E. J. F., Vermeijden, W. J., Masselink, J., Purmer, I. M., Bosma, L. E., Hoeksema, M., Wesselink, E., de Lange, D. W., de Keizer, N. F., Dongelmans, D. A. & Abu-Hanna, A., Jan 2024, In: British journal of clinical pharmacology. 90, 1, p. 164-175 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients

BreathDx Consortium, 15 Mar 2023, In: Clinical Infectious Diseases. 76, 6, p. 1059-1066 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Adverse drug event detection using natural language processing: A scoping review of supervised learning methods

Murphy, R. M., Klopotowska, J. E., de Keizer, N. F., Jager, K. J., Leopold, J. H., Dongelmans, D. A., Abu-Hanna, A. & Schut, M. C., Jan 2023, In: PLOS ONE. 18, 1 January, p. e0279842 e0279842.

Research output: Contribution to journal › Article › Academic › peer-review